173 related articles for article (PubMed ID: 24335340)
1. Evidences that estrogen receptor α interferes with adiponectin effects on breast cancer cell growth.
Mauro L; Pellegrino M; De Amicis F; Ricchio E; Giordano F; Rizza P; Catalano S; Bonofiglio D; Sisci D; Panno ML; Andò S
Cell Cycle; 2014; 13(4):553-64. PubMed ID: 24335340
[TBL] [Abstract][Full Text] [Related]
2. Uncoupling effects of estrogen receptor α on LKB1/AMPK interaction upon adiponectin exposure in breast cancer.
Mauro L; Naimo GD; Gelsomino L; Malivindi R; Bruno L; Pellegrino M; Tarallo R; Memoli D; Weisz A; Panno ML; Andò S
FASEB J; 2018 Aug; 32(8):4343-4355. PubMed ID: 29513571
[TBL] [Abstract][Full Text] [Related]
3. Hexachlorobenzene induces cell proliferation and IGF-I signaling pathway in an estrogen receptor alpha-dependent manner in MCF-7 breast cancer cell line.
García MA; Peña D; Alvarez L; Cocca C; Pontillo C; Bergoc R; de Pisarev DK; Randi A
Toxicol Lett; 2010 Feb; 192(2):195-205. PubMed ID: 19879930
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
[TBL] [Abstract][Full Text] [Related]
5. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells.
Song RX; Zhang Z; Chen Y; Bao Y; Santen RJ
Endocrinology; 2007 Aug; 148(8):4091-101. PubMed ID: 17525128
[TBL] [Abstract][Full Text] [Related]
6. Obesity enhances nongenomic estrogen receptor crosstalk with the PI3K/Akt and MAPK pathways to promote in vitro measures of breast cancer progression.
Bowers LW; Cavazos DA; Maximo IX; Brenner AJ; Hursting SD; deGraffenried LA
Breast Cancer Res; 2013; 15(4):R59. PubMed ID: 23880059
[TBL] [Abstract][Full Text] [Related]
7. Interfering Role of ERα on Adiponectin Action in Breast Cancer.
Naimo GD; Gelsomino L; Catalano S; Mauro L; Andò S
Front Endocrinol (Lausanne); 2020; 11():66. PubMed ID: 32132979
[TBL] [Abstract][Full Text] [Related]
8. ERα/LKB1 complex upregulates E-cadherin expression and stimulates breast cancer growth and progression upon adiponectin exposure.
Naimo GD; Forestiero M; Paolì A; Malivindi R; Gelsomino L; Győrffy B; Leonetti AE; Giordano F; Panza S; Conforti FL; Ruffo P; Panno ML; Mauro L; Andò S
Int J Cancer; 2023 Sep; 153(6):1257-1272. PubMed ID: 37323038
[TBL] [Abstract][Full Text] [Related]
9. A novel taspine derivative, HMQ1611, inhibits breast cancer cell growth via estrogen receptor α and EGF receptor signaling pathways.
Zhan Y; Zhang Y; Liu C; Zhang J; Smith WW; Wang N; Chen Y; Zheng L; He L
Cancer Prev Res (Phila); 2012 Jun; 5(6):864-73. PubMed ID: 22496388
[TBL] [Abstract][Full Text] [Related]
10. Triptolide inhibits human breast cancer MCF-7 cell growth via downregulation of the ERα-mediated signaling pathway.
Li H; Pan GF; Jiang ZZ; Yang J; Sun LX; Zhang LY
Acta Pharmacol Sin; 2015 May; 36(5):606-13. PubMed ID: 25864647
[TBL] [Abstract][Full Text] [Related]
11. Requirement of ERα and basal activities of EGFR and Src kinase in Cd-induced activation of MAPK/ERK pathway in human breast cancer MCF-7 cells.
Song X; Wei Z; Shaikh ZA
Toxicol Appl Pharmacol; 2015 Aug; 287(1):26-34. PubMed ID: 26006730
[TBL] [Abstract][Full Text] [Related]
12. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
[TBL] [Abstract][Full Text] [Related]
13. Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells.
Catalano S; Mauro L; Marsico S; Giordano C; Rizza P; Rago V; Montanaro D; Maggiolini M; Panno ML; Andó S
J Biol Chem; 2004 May; 279(19):19908-15. PubMed ID: 14985328
[TBL] [Abstract][Full Text] [Related]
14. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
[TBL] [Abstract][Full Text] [Related]
15. Role of estrogen receptor (ER) alpha in insulin-like growth factor (IGF)-I-induced responses in MCF-7 breast cancer cells.
Zhang S; Li X; Burghardt R; Smith R; Safe SH
J Mol Endocrinol; 2005 Dec; 35(3):433-47. PubMed ID: 16326831
[TBL] [Abstract][Full Text] [Related]
16. Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer.
Surmacz E; Bartucci M
J Exp Clin Cancer Res; 2004 Sep; 23(3):385-94. PubMed ID: 15595626
[TBL] [Abstract][Full Text] [Related]
17. Insulin Receptor Substrate Suppression by the Tyrphostin NT157 Inhibits Responses to Insulin-Like Growth Factor-I and Insulin in Breast Cancer Cells.
Yang Y; Chan JY; Temiz NA; Yee D
Horm Cancer; 2018 Dec; 9(6):371-382. PubMed ID: 30229539
[TBL] [Abstract][Full Text] [Related]
18. Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer.
Elbaz M; Ahirwar D; Ravi J; Nasser MW; Ganju RK
Oncotarget; 2017 May; 8(18):29668-29678. PubMed ID: 27213582
[TBL] [Abstract][Full Text] [Related]
19. Heregulin controls ERα and HER2 signaling in mammospheres of ERα-positive breast cancer cells and interferes with the efficacy of molecular targeted therapy.
Fukui F; Hayashi SI; Yamaguchi Y
J Steroid Biochem Mol Biol; 2020 Jul; 201():105698. PubMed ID: 32404282
[TBL] [Abstract][Full Text] [Related]
20. Cooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor-positive human breast cancer cells.
Herynk MH; Beyer AR; Cui Y; Weiss H; Anderson E; Green TP; Fuqua SA
Mol Cancer Ther; 2006 Dec; 5(12):3023-31. PubMed ID: 17172405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
